Closurerfs
Payments companies reported to CMS as associated with Closurerfs. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Closurerfs, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Closurerfs
These are the largest totals companies reported as associated with Closurerfs. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Rodney Raabe | Spokane, WA | Vascular & Interventional Radiology | $5,550.00 |
| Misaki Kiguchi | Washington, DC | Vascular Surgery | $4,200.00 |
| Dean Lomago | Butler, PA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $728.00 |
| Pratik Patel | Monroe, NJ | Cardiovascular Disease | $560.00 |
| Kenneth Sternberg | Fishersville, VA | Interventional Cardiology | $280.00 |
| Henry Siu | New York, NY | Interventional Cardiology | $280.00 |
| Christopher Molvar | Chicago, IL | Vascular & Interventional Radiology | $280.00 |
| Kofi Quaye | Houston, TX | Vascular Surgery | $280.00 |
| Ahmed Habib | Coshocton, OH | Cardiovascular Disease | $202.07 |
| Magdiel Trinidad Hernandez | Colorado Springs, CO | Vascular Surgery | $168.00 |
Prescribed Closurerfs?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.